Cure My Disease

Don't miss your cure!

 Log in / Sign up

New laser shows promise for varicose vein treatment in Head-to-Head trial

NCT ID NCT07603570

Disease control Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial compares two laser wavelengths (1940 nm vs 1470 nm) for closing off faulty veins in people with symptomatic varicose veins. 220 adults will be randomly assigned to one laser or the other. The main goal is to see which laser achieves complete vein closure at 6 months, with less pain and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
laser ablation (1940 nm or 1470 nm diode laser)
What this could lead to
If successful, this could show that a newer laser wavelength (1940 nm) works as well or better than the standard one, possibly with less pain and lower energy.
What could go wrong
This is a single-center trial, so results may not apply everywhere. Both lasers are already used; the main question is which is better, not whether the procedure works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 220 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Adult patients (≥18 years) diagnosed with symptomatic varicose veins. * Clinical, etiologic, anatomic, and pathophysiologic (CEAP) classification C2-C6. * Duplex ultrasound evidence of saphenous vein incompetence (reflux ≥0.5 seconds in standing position). * Great saphenous vein (GSV), small saphenous vein (SSV), or accessory saphenous vein diameter suitable for endovenous treatment (\<12 mm). * Patients able to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Great saphenous vein (GSV) with venous reflux disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

varicose disease venous insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Great saphenous vein (GSV) with venous reflux disease Varicose veins of lower limb

Contacts and locations

Locations

  • KSUH

    Kafr ash Shaykh, 33516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.